Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials
- Resource Type
- Article
- Authors
- Bar-Or, Amit; Thanei, Gian-Andrea; Harp, Christopher; Bernasconi, Corrado; Bonati, Ulrike; Cross, Anne H.; Fischer, Saloumeh; Gaetano, Laura; Hauser, Stephen L.; Hendricks, Robert; Kappos, Ludwig; Kuhle, Jens; Leppert, David; Model, Fabian; Sauter, Annette; Koendgen, Harold; Jia, Xiaoming; Herman, Ann E.
- Source
- In eBioMedicine July 2023 93
- Subject
- Language
- ISSN
- 2352-3964